Fingerprint
Dive into the research topics of 'Every-2-week darbepoetin alfa is comparable to rHuEPO in treating chemotherapy-induced anemia. Results of a combined analysis.'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Every-2-week darbepoetin alfa is comparable to rHuEPO in treating chemotherapy-induced anemia. Results of a combined analysis.
Barry Mirtsching, Veena Charu, Saroj Vadhan-Raj, Alan B. Colowick, Gregory Rossi, Dianne Tomita, William P. McGuire
Research output: Contribution to journal › Article › peer-review
24
Scopus
citations